This is what makes Bio-Techne Corp. (TECH) an excellent investment in stocks
Baron Funds, an asset management company, has published its third quarter 2021 “Baron Health Care Fund” letter to investors – a copy of which can be found downloaded here. A return of 1.18% was generated by the institutional stocks of the fund for the third quarter of 2021, outperforming both its benchmarks S&P 500 and Russell 3000 Health Care which generated returns of 0.58% and 0, 17% respectively for the same period. You can check out the top 5 holdings in the fund to get a feel for their top picks for 2021.
Baron Fund, in its letter to investors for Q3 2021, mentioned Bio-Techne Corporation (NASDAQ: TECHNOLOGY) and discussed his position on the company. Bio-Techne Corporation is a Minneapolis, Minnesota corporationbiotechnology company based on a market capitalization of $ 19.5 billion. TECH has achieved a 56.61% year-to-date return, while its 12-month returns are up 64.42%. The stock closed at $ 497.32 per share on November 5, 2021.
Here’s what Baron Funds has to say about Bio-Techné Company in his letter to investors Q3 2021:
“The strength in the sub-industry also came from the developer of tools for the life sciences Bio-Techne Corporation. Bio-Techne stock rose in response to strong quarterly financial results and a bullish investor day. “
Pressmaster / Shutterstock.com
Based on our calculations, Bio-Techne Corporation (NASDAQ: TECH) failed to land a spot on our list of 30 most popular stocks among hedge funds. TECHNOLOGY was in 25 hedge fund portfolios at the end of the first half of 2021, compared to 23 funds in the previous quarter. Bio-Techne Corporation (NASDAQ: TECH) generated a return of 3.22% in the last 3 months.
The reputation of hedge funds as savvy investors has been tarnished over the past decade, as their hedged returns could not keep up with the unhedged returns of stock indices. Our research has shown that small-cap hedge fund stock selection managed to beat the market by double digits every year between 1999 and 2016, but the margin for outperformance has shrunk in recent years. Nonetheless, we were still able to identify in advance a select group of hedge funds that have outperformed S&P 500 ETFs by 115 percentage points since March 2017 (see details here). We were also able to identify ahead of time a select group of hedge funds that underperformed the market by 10 percentage points per year between 2006 and 2017. Interestingly, the margin of underperformance of these stocks has increased in recent years. Investors who are long in the market and short on these stocks would have reported over 27% per year between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.
At Insider Monkey, we scour multiple sources to uncover the next big investing idea. For example, billionaire John Paulson takes care of the miners, so we check out stock locations like this mining stocks. We go through lists like the 10 best EV stocks to choose the next Tesla which will offer a 10x return. Even though we only recommend positions in a tiny fraction of the companies we analyze, we check as many stocks as possible. We read letters from hedge fund investors and listen to the equity pitches at hedge fund conferences. You can subscribe to our free daily newsletter at our home page.
Disclosure: none. This article was originally published on Monkey initiate.